Epiminder Ltd Market Cap ($40.63K)
Market Cap & Net Worth: Epiminder Ltd (EPI)
Epiminder Ltd market cap. Epiminder Ltd (AU:EPI) has a market capitalization of $40.63K (AU$57.42K) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31706 globally and #1817 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epiminder Ltd's stock price AU$0.27 by its total outstanding shares 216672 (216.67K). Also see EPI cash flow metrics for how efficiently the company converts equity into cash flow.
Epiminder Ltd Market Cap History (2025–2026)
Epiminder Ltd market cap history from 2025 to 2026. Data shows growth from $156.38K to $40.63K (0.00% CAGR). Check EPI live share price for real-time trading data and today's change.
Epiminder Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epiminder Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Epiminder Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.35x
Epiminder Ltd's market cap is 0.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $156.38K | $445.18K | -$31.78 Million | 0.35x | N/A |
Competitor Companies of EPI by Market Capitalization
Companies near Epiminder Ltd in the global market cap rankings as of November 7, 2026. Also see Epiminder Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Epiminder Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Epiminder Ltd (2025–2026)
Market capitalization of Epiminder Ltd from 2025 to today. Between 2025 and today, Epiminder Ltd's market cap moved from $156.38K to $ 40.63K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$40.63K | -74.02% |
| 2025 | AU$156.38K | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Epiminder Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.63K USD |
| MoneyControl | $40.63K USD |
| MarketWatch | $40.63K USD |
| marketcap.company | $40.63K USD |
| Reuters | $40.63K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more